Clinical trials in Leidschendam – page 120

Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

• Advanced NSCLC treatments
• Immunotherapy combinations
• KRAS G12C inhibitors

Studies compare various treatment options to improve patient outcomes and survival rates.

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.

• Metastatic breast cancer
• HER2-positive therapy
• Triple-negative breast cancer

Trials examine innovative treatment strategies and personalized approaches.

Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.

• Advanced Hodgkin Lymphoma
• Follicular Lymphoma
• Treatment optimization

Research aims to improve treatment outcomes while minimizing toxicity.

Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.

• Rectal cancer treatments
• Esophagogastric cancer
• Surgical innovations

Focus on improving surgical outcomes and treatment effectiveness.

Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.

• Radiation necrosis treatment
• Metastatic detection
• Targeted therapies

Research aims to improve detection and treatment of brain metastases.